Laura Clague

Chief Financial Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

TVTX

CFO

10 calls Latest call 2022-08-04

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Travere Therapeutics, Inc. (TVTX)	Former Chief Financial Officer	$422,476	—	$761,200	$538,929	$222,600	$18,138	$1,963,343
2021	Travere Therapeutics, Inc. (TVTX)	Former Chief Financial Officer	$452,072	—	$403,200	$791,194	$271,625	$16,580	$1,934,671
2020	Travere Therapeutics, Inc. (TVTX)	Former Chief Financial Officer	$436,801	—	$432,880	$508,217	$254,239	$16,577	$1,648,714
2019	Travere Therapeutics, Inc. (TVTX)	Senior Vice President and Chief Financial Officer	$419,271	—	$215,520	$453,000	$200,747	$15,044	$1,303,582
2018	Travere Therapeutics, Inc. (TVTX)	Senior Vice President and Chief Financial Officer	$399,583	—	$497,803	$769,522	$185,150	$8,250	$1,860,308
2017	Travere Therapeutics, Inc. (TVTX)	Senior Vice President and Chief Financial Officer	$382,467	—	$304,913	$671,220	$129,938	$8,100	$1,496,638

Earnings-call appearances and filed executive appointments or departures, newest first.